Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Burrai, Giovanni P ^a,b   Mohammed, Sulma I ^b,e,f   Miller, Margaret A ^b   Marras, Vincenzo ^c   Pirino, Salvatore ^a   Addis, Maria F ^d   Uzzau, Sergio ^d   Antuofermo, Elisabetta ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF SASSARI   (Italy)

^d Porto Conte Ricerche Srl   (Italy)

^e Purdue University   (United States)

^f PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST LESION; CANCER CLASSIFICATION; CANCER INVASION; CANCER RISK; CAT DISEASE; CONTROLLED STUDY; DUCTAL HYPERPLASIA; EPITHELIUM CELL; FELINE MAMMARY TUMOR; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; NONHUMAN; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CARCINOMA IN SITU; CAT; DISEASE MODEL; EXPERIMENTAL NEOPLASM; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY;

ANIMALS; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CATS; DISEASE MODELS, ANIMAL; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; RECEPTOR, ERBB-2; RECEPTORS, PROGESTERONE;

EID: 77951042246     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-156     Document Type: Article

References (47)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 58:71-96.
2. O'Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ, Sigman CC, Bertagnolli MM, Stratton SP, Lam S, Nelson WG, Meyskens FL, Alberts DS, Follen M, Rustgi AK, Papadimitrakopoulou V, Scardino PT, Gazdar AF, Wattenberg LW, Sporn MB, Sakr WA, Lippman SM, Von Hoff DD. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 2002, 8:314-46.
3. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985, 312(3):146-51.
4. Page DL, Jensen RA, Simpson JF, Dupont WD. Historical and epidemiologic background of human premalignant breast disease. J Mammary Gland Biol Neoplasia 2000, 5:341-349. 10.1023/A:1009521726605, 14973380.
5. Arpino G, Laucirica R, Elledge RM. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 2005, 143:446-457.
6. Hansen K, Khanna C. Spontaneous and genetically engineered animal models: use in preclinical cancer drug development. Eur J Cancer 2004, 40(6):858-80. 10.1016/j.ejca.2003.11.031, 15120042.
7. Allred DC, Medina D. The relevance of mouse models to understanding the development and progression of human breast cancer. J Mammary Gland Biol Neoplasia 2008, 13(3):279-88. 10.1007/s10911-008-9093-5, 18704660.
8. Porrello A, Cardelli P, Spugnini EP. Oncology of companion animals as a model for humans. An overview of tumor histotypes. J Exp Clin Cancer Res 2006, 25(1):97-105.
9. Weijer K, Head KW, Misdorp W, Hampe JF. Feline malignant mammary tumors. I. Morphology and biology: some comparisons with human and canine mammary. J Natl Cancer Inst 1972, 49:1697-704.
10. MacEwen EG. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev 1990, 9:125-36. 10.1007/BF00046339, 2253312.
11. Misdorp W. Tumors of the mammary gland. Tumors in domestic animals 2002, 575-606. Iowa: Blackwell, Meuten DJ, 4.
12. Zappulli V, De Zan G, Cardazzo B, Bargelloni L, Castagnaro M. Feline mammary tumours in comparative oncology. Journal of Dairy Research 2005, 72(Special):98-106. 10.1017/S0022029905001263, 16180727.
13. Overley B, Shofer FS, Goldschmidt MH, Sherer D, Sorenmo KU. Association between ovariohysterectomy and feline mammary carcinoma. J Vet Intern Med 2005, 19:560-563.
14. Misdorp W, Romijn A, Hart AA. Feline mammary tumors: a case-control study of hormonal factors. Anticancer Res 1991, 11:1793-1797.
15. Misdorp W. Progestagens and mammary tumours in dogs and cats. Acta Endocrinol 1991, 125:27-31.
16. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993, 15:36-47.
17. McGuire WL, Osborne CK, Clark GM, Knight WA. Steroid hormone receptors and carcinoma of the breast. Am J of Physiol 1982, 243:99-102.
18. Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Wärri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M, Gustafsson JA. Estrogen receptor beta in breast cancer. Endocr Relat Cancer 2002, 9:1-13. 10.1677/erc.0.0090001, 11914179.
19. Allred DC, Brown P, Medina D. The origins of estrogen receptor positive and negative human breast cancer. Breast Cancer Res 2004, 6:240-245. 10.1186/bcr938, 1064085, 15535853.
20. de las Mulas JM, van Niel M, Millan Y, Blankenstein MA, van Mil F, Misdorp W. Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay. Domest Anim Endocrinol 2000, 18:111-125. 10.1016/S0739-7240(99)00067-3, 10701768.
21. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001, 411:355-365. 10.1038/35077225, 11357143.
22. Sahin AA. Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer. Adv Anat Pathol 2000, 7:158-166. 10.1097/00125480-200007030-00005, 10809222.
23. De Maria R, Olivero M, Iussich S, Nakaichi M, Murata T, Biolatti B, Di Renzo MF. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. Cancer Res 2005, 65:907-912.
24. Ordás J, Millán Y, Dios R, Reymundo C, de las Mulas JM. Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study. BMC Cancer 2007, 7:179. 10.1186/1471-2407-7-179, 2045669, 17880730.
25. Millanta F, Calandrella M, Citi S, Della Santa D, Poli A. Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey an evaluation of its prognostic potential. Vet Pathol 2005, 42:30-34. 10.1354/vp.42-1-30, 15657269.
26. Rosen PP. Rosen's breast pathology 2001, Lippincott Williams & Wilkins: Philadelphia, PA, 2.
27. The Consensus Conference Committee Consensus conference on the classification of ductal carcinoma in situ. Cancer 1997, 80:1798-1802. 10.1002/(SICI)1097-0142(19971101)80:9<1798::AID-CNCR15>3.0.CO;2-0, 9351550, The Consensus Conference Committee.
28. Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R, Page DL. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992, 16:1133-43. 10.1097/00000478-199212000-00001, 1463092.
29. Misdorp W, Else RW, Hellmen E, Limpiscomb TP. Histological classification of the mammary tumors of the dog and the cat. World Health Organization International Histological Classification of Tumors of Domestic Animals. 2nd Series 1999, 7. Washington, D.C: Armed Force Institute of Pathology.
30. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410. 10.1111/j.1365-2559.1991.tb00229.x, 1757079.
31. Castagnaro M, Casalone C, Bozzetta E, De Maria R, Biolatti B, Caramelli M. Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas. J Comp Pathol 1998, 119:263-275. 10.1016/S0021-9975(98)80049-2, 9807728.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685. 10.1038/227680a0, 5432063.
33. Westermeier R. Sensitive, quantitative and fast modifications for Coomassie blue staining of polyacrilamide gels. Proteomics 2006, 6:61-64. 10.1002/pmic.200690121, 17031800.
34. Seixas F, Palmeira C, Pires MA, Lopesn C. Mammary invasive micropapillary carcinoma in cats: clinicopathologic features and nuclear DNA content. Vet Pathol 2007, 44(6):842-848. 10.1354/vp.44-6-842, 18039897.
35. Boughey JC, Gonzalez RJ, Bonner E, Kuerer HM. Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist 2007, 12:1276-1287. 10.1634/theoncologist.12-11-1276, 18055847.
36. Cardiff RD, Moghanaki D, Jensen RA. Genetically engineered mouse models of mammary intraepithelial neoplasia. J Mammary Gland Biol Neoplasia 2000, 5:421-437. 10.1023/A:1009534129331, 14973386.
37. Munson L, Moresco A. Comparative pathology of mammary gland cancers in domestic and wild animals. Breast Dis 2007, 28:7-21.
38. Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993, 71:1258-1265. 10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I, 8435803.
39. Khan SA, Rogers MA, Khurana KK, Meguid MM, Numann PJ. Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 1998, 90:37-42. 10.1093/jnci/90.1.37, 9428781.
40. Millanta F, Calandrella M, Vannozzi I, Poli A. Steroid hormone receptors in normal, dysplastic and neoplastic feline mammary tissues and their prognostic significance. Vet Rec 2006, 158:821-824.
41. de las Mulas JM, Van Niel M, Millán Y, Blankenstein MA, Van Mil F, Misdorp W. Progesterone receptors in normal, dysplastic and tumorous feline mammary glands. Comparison with oestrogen receptors status. Res Vet Sci 2002, 72:153-161. 10.1053/rvsc.2001.0542, 12027597.
42. Millanta F, Lazzeri G, Mazzei M, Vannozzi I, Poli A. MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis. Vet Pathol 2002, 39:120-126. 10.1354/vp.39-1-120, 12102203.
43. Dias Pereira P, Carvalheira J, Gärtner F. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue - an immunohistochemical study. Vet J 2004, 168:180-185. 10.1016/j.tvjl.2003.10.018, 15301767.
44. Castagnaro M, De Maria R, Bozzetta E, Ru G, Casalone C, Biolatti B, Caramelli M. Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas. Res Vet Sci 1998, 65:223-226. 10.1016/S0034-5288(98)90147-3, 9915147.
45. Gullick WJ, Srinivasan R. The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer. Breast Cancer Res Treat 1998, 52:43-53. 10.1023/A:1006107016969, 10066071.
46. Dowsett M, Cooke T, Ellis I, Gullick WJ, Gusterson B, Mallon E, Walker R. Assessment of HER2 status in breast cancer: why, when and how?. Eur J Cancer 2000, 36(2):170-176. 10.1016/S0959-8049(99)00264-6, 10741274.
47. Antuofermo E, Miller MA, Pirino S, Xie J, Badve S, Mohammed SI. Spontaneous mammary intraepithelial lesions in dogs - a model of breast cancer. Cancer Epidemiol Biomarkers Prev 2007, 16(11):2247-2256. 10.1158/1055-9965.EPI-06-0932, 17982119.